SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-019563
Filing Date
2012-04-02
Accepted
2012-04-02 17:30:59
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v307199_10k.htm 10-K 887619
2 EXHIBIT 23.1 v307199_ex23-1.htm EX-23.1 2327
3 EXHIBIT 31.1 v307199_ex31-1.htm EX-31.1 7190
4 EXHIBIT 31.2 v307199_ex31-2.htm EX-31.2 7131
5 EXHIBIT 32.1 v307199_ex32-1.htm EX-32.1 3728
6 EXHIBIT 32.2 v307199_ex32-2.htm EX-32.2 3702
  Complete submission text file 0001144204-12-019563.txt   2765399

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nltx-20111231.xml EX-101.INS 284523
8 XBRL TAXONOMY EXTENSION SCHEMA nltx-20111231.xsd EX-101.SCH 20466
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20111231_cal.xml EX-101.CAL 32846
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20111231_def.xml EX-101.DEF 108640
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20111231_lab.xml EX-101.LAB 137625
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20111231_pre.xml EX-101.PRE 128949
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34058 | Film No.: 12734700
SIC: 2834 Pharmaceutical Preparations